AlivaMab Discovery Services Announces Multi-Target Agreement with Janssen

SAN DIEGO–(BUSINESS WIRE)–AlivaMab Discovery Services, LLC, a company providing custom human therapeutic antibody drug discovery services using the AlivaMab? Mouse, a best-in-class antibody discovery platform, today announced a multi-target discovery agreement with Janssen Research & Development, LLC (Janssen). Under the agreement, ADS will provide its expertise and capabilities to generate and deliver therapeutic antibody candidates to Janssen for further evaluation. "We are pleased that